Pliant Therapeutics Stock Price Chart


Pliant Therapeutics

Last Price:
Seasonality Move:

7 Day Trial


$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing slight selling pressure.

Pliant Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 11.64 Buy
20-day SMA: 12.62 Sell
50-day SMA: 13.11 Sell
200-day SMA: 15.2 Sell
8-day EMA: 11.81 Sell
20-day EMA: 12.34 Sell
50-day EMA: 13.18 Sell
200-day EMA: 15.5 Sell

Pliant Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 40.53 Sell
Chaikin Money Flow: -75619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.62 - 14.38) Sell
Bollinger Bands (100): (12.69 - 16.39) Sell

Pliant Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Pliant Therapeutics Stock

Is Pliant Therapeutics Stock a Buy?

PLRX Technical Analysis vs Fundamental Analysis

Pliant Therapeutics (PLRX) is a Sell

Is Pliant Therapeutics a Buy or a Sell?

Pliant Therapeutics Stock Info

Market Cap:
Price in USD:
Share Volume:

Pliant Therapeutics 52-Week Range

52-Week High:
52-Week Low:
Pliant Therapeutics (PLRX) is a Sell

Pliant Therapeutics Share Price Forecast

Is Pliant Therapeutics Stock a Buy?

  • Pliant Therapeutics share price is 11.80 while PLRX 8-day exponential moving average is 11.81, which is a Sell signal.
  • The stock price of PLRX is 11.80 while Pliant Therapeutics 20-day EMA is 12.34, which makes it a Sell.
  • Pliant Therapeutics 50-day exponential moving average is 13.18 while PLRX share price is 11.80, making it a Sell technically.
  • PLRX stock price is 11.80 and Pliant Therapeutics 200-day simple moving average is 15.50, creating a Sell signal.

Fundamental Analysis of Pliant Therapeutics

Is Pliant Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.27 per share.

Technical Analysis of Pliant Therapeutics

Should I short Pliant Therapeutics stock?

* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.